TandemAI has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced ...

Merck has entered a definitive agreement to acquire Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate ...

3Q Earnings: $186 million (earnings were $1.6B 3Q24) YTD Revenues: $44.5 billion (+8%) YTD Earnings: $2.4 billion (-44%) ...

The U.S. Department of Health and Human Services (HHS) and the U.S. FDA, has appointed Richard Pazdur, M.D., as director of ...

Domain Therapeutics, a clinical-stage biopharmaceutical company, has appointed Jean-Marie Cuillerot, M.D., as Chief Medical ...

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, appointed Carlos Martin as Chief ...

Q Earnings: $5.8 billion (+83%) YTD Revenues: $48.6 billion (flat) YTD Earnings: $15.3 (+14%) Comments: KEYTRUDA sales were up 10% to $8.1 billion driven by continued global demand and uptake in ...

Global biopharmaceutical sales were $16.3 billion, down 6%. Primary Care sales were down 16% to $7.6 billion. Eliquis sales were up 22% to $2.0 billion. Prevnar sales were down 3% to $1.7 billion.

BostonGene and Kyoto University have entered a research collaboration to develop advanced biological signatures.

Panthera Biopartners, a UK Site Management Organization (SMO) which runs commercial clinical trials for the pharmaceutical ...

Ji will drive strategic planning, operations, and the continued expansion of the company’s development and manufacturing ...

Leukogene Therapeutics Inc., a biopharmaceutical company developing next-generation therapies for hematologic and other ...